Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism.

Monitoring drug-induced side effects is especially important for patients who undergo treatment with antipsychotic medications, as these drugs often produce extrapyramidal side effects (EPS) resulting in movement abnormalities similar to parkinsonism. Scientists have developed several objective laboratory tests to measure and research drug-induced movement disorders, but equipment and tests are complex and costly and have not become accepted in large-scale, multi-site clinical trials. The goals of this study were to test whether a simple handwriting measure can discriminate between individuals with psychotropic-induced parkinsonism, Parkinson's disease, and healthy individuals, and to examine some of the psychometric properties of the measure. We examined pen movement kinematics during cursive writing of a standard word in 13 patients with idiopathic Parkinson's disease (PD), 10 schizophrenia patients with drug-induced parkinsonism (SZ), and 12 normal healthy control participants (NC). Participants were instructed to write the word "hello" in cursive twice, at three vertical height scales. Software was used for data acquisition and analysis of vertical stroke velocities, velocity scaling, and smoothness. There were four important results from this study: (1) both SZ patients with drug-induced EPS and PD participants exhibited impaired movement velocities and velocity scaling; (2) performance on the velocity scaling measure distinguished drug-induced EPS from normal with 90% accuracy; (3) SZ, but not PD participants displayed abnormalities in movement smoothness; and (4) there was a positive correlation between age and magnitude of the velocity scaling deficit in PD participants. This study demonstrates that kinematic analyses of pen movements during handwriting may be useful in detecting and monitoring subtle changes in motor control related to the adverse effects of psychotropic medications.

[1]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[2]  W. Ondo,et al.  Evaluating factors that can influence spirography ratings in patients with essential tremor. , 2005, Parkinsonism & related disorders.

[3]  A. Seese,et al.  Verkleinerung der Handschriftfläche und D2-Dopaminrezeptorblockade Ergebnisse unter Behandlung mit typischen und atypischen Neuroleptika , 2000, Der Nervenarzt.

[4]  H Wetzel,et al.  Extrapyramidal Symptoms and their Relationship to Clinical Efficacy under Perphenazine Treatment* , 1991, Pharmacopsychiatry.

[5]  G E Stelmach,et al.  Parkinson’s disease patients undershoot target size in handwriting and similar tasks , 2003, Journal of neurology, neurosurgery, and psychiatry.

[6]  K. Syndulko,et al.  Human Neurologic Function and the Aging Process † , 1980, Journal of the American Geriatrics Society.

[7]  José Luis Contreras-Vidal,et al.  A neural model of basal ganglia-thalamocortical relations in normal and parkinsonian movement , 1995, Biological Cybernetics.

[8]  S. Fahn,et al.  The characterization and outcome of stereotypic movements in nonautistic children , 1997, Movement disorders : official journal of the Movement Disorder Society.

[9]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .

[10]  J. Hollerbach An oscillation theory of handwriting , 2004, Biological Cybernetics.

[11]  G. Stelmach,et al.  Parkinsonian Patients Reduce Their Stroke Size with Increased Processing Demands , 2001, Brain and Cognition.

[12]  A. Wing,et al.  Agraphia and micrographia: clinical manifestations of motor programming and performance disorders. , 1983, Acta psychologica.

[13]  G. Stelmach,et al.  FORCE AMPLITUDE AND FORCE DURATION IN PARKINSONIAN HANDWRITING , 1991 .

[14]  G. Stelmach,et al.  Tutorials in motor neuroscience , 1991 .

[15]  Alexander Storch,et al.  Early diagnosis of Parkinson’s disease , 2006, Journal of Neurology.

[16]  Daniel M Corcos,et al.  Effect of medication on EMG patterns in individuals with Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[17]  G. Stelmach,et al.  Parkinsonism Reduces Coordination of Fingers, Wrist, and Arm in Fine Motor Control , 1997, Experimental Neurology.

[18]  Stephen Grossberg,et al.  A neural network model for cursive script production , 1993, Biological Cybernetics.

[19]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[20]  Dc Washington Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[21]  A. Malla,et al.  Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naïve schizophrenia patients , 2005, Schizophrenia Research.

[22]  Haase Hj Extrapyramidal modification of fine movements: a "conditio sine qua non" of the fundamental therapeutic action of neuroleptic drugs. , 1961 .

[23]  D. Jeste,et al.  Antipsychotic-Induced Movement Disorders in the Elderly , 2000, Drugs & aging.

[24]  D M Corcos,et al.  Control of movement distance in Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[25]  M. Hallett,et al.  Pathophysiology of bradykinesia in Parkinson's disease. , 2001, Brain : a journal of neurology.

[26]  Hermann-Josef Gertz,et al.  Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs , 1999, Psychiatry Research: Neuroimaging.

[27]  M. Stacy,et al.  Movement disorders and normal aging. , 2001, Neurologic clinics.

[28]  J. Lohr,et al.  A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients , 1994, Biological Psychiatry.

[29]  Tipu Z. Aziz,et al.  The direction of oscillation in spiral drawings can be used to differentiate distal and proximal arm tremor , 2005, Neuroscience Letters.

[30]  Shouyan Wang,et al.  Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks , 2005, Journal of Neuroscience Methods.

[31]  S. Leucht,et al.  New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis , 2003, The Lancet.

[32]  H. Haase The purely neuroleptic effects and its relation to the "neuroleptic threshold". , 1978, Acta psychiatrica Belgica.